共 50 条
- [21] Heroin and cannabis use is declining but new drugs show increase, says EU reportBMJ-BRITISH MEDICAL JOURNAL, 2014, 348Watson, Rory
- [22] A probabilistic model to assess the cost-effectiveness of a new statin (Rosuvastatin) in the UKVALUE IN HEALTH, 2003, 6 (06) : 649 - 650Palmer, SBrady, AJRatcliffe, A
- [23] Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdleBMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7472): : 972 - 975Taylor, RSDrummond, MFSalkeld, GSullivan, SD
- [24] Legal tactics to delay launch of generic drugs cost Europe (euro)3bn, report saysBRITISH MEDICAL JOURNAL, 2008, 337Jack, Andrew
- [25] Only 3 in 20 new drugs approved in Germany in 2011 were an improvement, report saysBMJ-BRITISH MEDICAL JOURNAL, 2014, 348Stafford, Ned
- [26] US politicians want federal funding to discover cost effectiveness of new drugsBRITISH MEDICAL JOURNAL, 2003, 327 (7416): : 642 - 642Moynihan, R
- [27] Methods of cost effectiveness analysis in the assessment of new drugs for Alzheimer's diseasePSYCHIATRIC SERVICES, 1997, 48 (11) : 1440 - 1444Neumann, PJHermann, RCBerenbaum, PAWeinstein, MC
- [28] How should we assess the value of innovative drugs in oncology? Lessons from cost-effectiveness analysesBLOOD, 2015, 126 (15) : 1860 - 1861Prasad, VinayMailankody, Sham
- [29] A GLOBAL ECONOMIC MODEL TO ASSESS THE COST EFFECTIVENESS OF NEW TREATMENTS FOR ADVANCED BREAST CANCER IN CANADAVALUE IN HEALTH, 2016, 19 (03) : A151 - A151Beauchemin, C.Letarte, N.Mathurin, K.Yelle, L.Lachaine, J.
- [30] HCV first drugs generation: cost/effectiveness profile in view of new therapeutic algorithmINTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 490 - 491Capano, F.Filieri, A.Lerda, C.Buscaino, A.Ielo, D.Saracco, G. M.